Combined heart and liver transplantation for familial amyloidosis

Internal Medicine Journal

Volumn 31, Issue 1, 2001, Pages 66-67

  Ruygrok, Peter ^a   Gane, E J ^b   Mccall, J L ^b   Chen, X Z ^a   Haydock, D A ^a   Munn, S R ^b  

^a GREEN LANE HOSPITAL   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; DNA; IMMUNOSUPPRESSIVE AGENT; PREALBUMIN; PREDNISONE; THYMOCYTE ANTIBODY;

ADULT; AMYLOIDOSIS; ARTICLE; CASE REPORT; FAMILIAL DISEASE; GENE MUTATION; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MALE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

AMYLOIDOSIS, FAMILIAL; HEART TRANSPLANTATION; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 0035018747     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1445-5994.2001.00008.x     Document Type: Article

References (6)

1. Transthyretin TYR77 familial amyloid polyneuropathy: A clinicopathological study of a large kindred
2. Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation
3. Clinical improvement after liver transplantation for type I familial amyloid polyneuropathy
4. Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy
5. Progression of ventricular wall thickening after liver transplantation for familial amyloidosis
6. Successful combined liver-heart transplantation in adults: Report of three patients and review of the literature